Dressed to Kill
The Link Between Breast Cancer and Bras
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Acheter pour 25,00 $
Aucun mode de paiement valide enregistré.
Nous sommes désolés. Nous ne pouvons vendre ce titre avec ce mode de paiement
-
Narrateur(s):
-
Diane Neigebauer
-
Auteur(s):
-
Sydney Ross Singer
-
Soma Grismaijer
À propos de cet audio
Breast cysts and cancer are epidemic at this time in history. The healthcare industry says that the cause of 70 percent of all breast cancer is unknown. Dressed to Kill helps solve this mystery, explaining how one of the greatest threats to breast health is something that women do to themselves every day.
This book has its roots in a personal crisis in the authors’ lives, when Soma Grismaijer was shocked to find a lump in her breast while pregnant. Looking for clues that might point to the origin of this lump led the husband-and-wife medical anthropology team to develop a new theory and to conduct an extensive survey of nearly 5,000 United States women, half of whom had breast cancer, in an attempt to uncover a hidden cause of this devastating disease.
In Dressed to Kill, authors Singer and Grismaijer, pioneers in the field of applied medical anthropology, explain their unique approach to researching and understanding the cultural causes of disease in an easy-to-listen language that is accessible to the layperson and the professional alike.
This book has already had an impact on the healthcare and fashion worlds, moving some doctors to rethink the prevention and treatment of breast disease and some clothing designers to rethink their products. Controversial for its challenge to established custom and medical dogma, this breakthrough work is a classic, and in this updated edition, it continues to suggest new ways of dealing with an old and all-too-common women’s health issue.
©2018 Sydney Ross Singer and Soma Grismaijer (P)2019 Square One Publishers, Inc.